2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: Heart disease and stroke statistics-2012 Update: A report from the American Heart Association. Circulation 2012; 125(1): 188-97.
3. Rubinstein R, Colantonio L, Bardach A, Caporale J, GarcíaMartí S, Kopitowski K, et al. Estimation
4. of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina. BMC Public Health. 2010; 10:627.
5. Hatami ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: A population based survey. Cardiovascular Disorders 2007; 7: 32. [persion]
6. Khodaveisi M, Yaghobi A, Borzou R. Prevalence of cardiovascular risk factors among Hamedeni adolescents. J School of Public Health and Insttute of Public Health Res 2011; 8(4): 31-9
7. Akbari Z, Mohammadi M, Effati B, Arsang jang S, Aboalkhirian S, Barati H. The Survey on the Prevalence of the Cardiovascular Diseases Risk Factors among the Qom University of Medical Sciences Staffs in 2012. Paramedical Sciences and Military Health. 2016; 11 (2) :1-7.
8. Tilling K, Sterne JA, Szklo M. estimating the effect of cardiovascular risk factors on all-cause mortality and incidence of coronary heart disease using G-estimation: the atherosclerosis risk in communities study. Am J Epidmiol 2002; 155(8): 710-8
9. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. Geneva WHO Press. 2007
10. Zarenezhad M, Farshidi H, Zaree SH. Inevstigating The Awareness of Inter-City Bus Drivers and Truck Drivers on Coronary Heart Disease Risk Factors. Hormozgan medical j 2012; 16(4): 299-307.
11. Asgari F, Mirzazadeh A, Heidarian H. 3rd national Surveillance of Risk Factors of Non Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. Ministry of Health and Medical Education 2009; 9: 167.
12. Hadaegh F, Khalili D, Fahimfar N, Tohid M, Eskandari F, Azizi F. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-upof the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest 2009; 32(9): 724-30
13. Solimani Z, Barati H, Mozafari Join A, Ershadi Moqadam H, Mohammadi M. The Quality of Life of Patients with Diabetes from the City of Sabzevar During Year 2016. Military Caring Sciences. 2017; 3 (4). 264-271.
14. Ershadi Moqadam H, Barati H, Solimani Z, Mohammadi M. Evaluating the Risk Factors of Type II Diabetes in Sabzevar. Paramedical Sciences and Military Health. 2017; 12 (1): 24-31
15. Mohammadi M. The concept of population attributable fraction (PAF), and the potential impact fraction (PIF) in epidemiology: letters to the editor. Tehran Uni Med J (TUMJ) 2016; 74(1): 75.[persion]
16. Mohammadi M, Mirzaei M. Population Attributable Fraction of Hypertension Associated with Obesity in Yazd Province in 2009: A Short Report. J RafsanjanUni Med Sci 2014; 13(10): 1179-86.[persion]
17. Mohammadi M, Mirzaei M. Population attributable fraction of hypertension associated with obesity in the Western Iran. Razi J Med Sci 2016; 23(144): 81-88
18. Mohammadi M, Mirzaei M. Population Attributable Fraction of Hypertension Associated with Obesity in Iran. J Community Health Res 2016; 5(4): 249-259. [Persion]
19. Mohammadi M, Mirzaei M. Population-attributable fraction of hypertension associated with obesity,abdominal obesity, and the joint effect of both in the Central Provinces of Iran. J Epidemiology and Global Health 2017; 7(1): 71–79. [persion]
20. Mohammadi M, Mirzaei M. Barati H. The Estimated Joint Impact of Obesity and Abdominal Obesity in the Prevalence of Hypertension of Males of Qom City: The Study of Population-Attributable Fraction. Military caring Sci 2016; 3(2): 133-138. [persion]
21. Mohammadi M, Mirzaei M. The effect of obesity, abdominal obesity and joint effect of them on high blood pressure in men of Mazandaran Province, Iran (population attributable fraction study): brief report. Tehran Uni Med J (TUMJ) 2017; 74(10): 735-740. [persion]
22. Karami M, Khosravi shadmani F, Najafi F. Estimating the contribution of diabetes on the attributable burden of cardiovascular diseases in Kermanshah, West of Iran. Iranian J Epidemiology 2012; 8(3): 33-38. [persion]
23. Rasoli M, Mohseni Kiasari A, Mokhberi V, Bagheri B, Daneshpour N, Shariati R, et al. Global risk assessment of coronary heart disease using Framingham's scores for major risk factors. J Mazandaran Med Uni 2006; 15(50): 49- 62.[Persion]
24. Heshmati H, Behnampour N, KHorasani F, Moqadam Z. The prevalence of chronic complications of diabetes and its risk factors in patients with type II diabetes mellitus city center Fereidoon'kenar. Journal of Neyshabur University of Medical Sciences.2014;1(1):36-42
25. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006; 368(9548): 1651-9.[Persian]
26. Taghipour B, Sharifi Nia H, Kaveh H, Heidaranlu E, Shahidi Far S, Emami zeydi A, et al. Clinical manifestations of myocardial infarction in diabetic and non-diabetic patients. Iran J Crit Care Nurs 2014; 7(2):120-127.[persion]
27. Karami M, Khalili D, Eshrati B. Estimating the Proportion of Diabetes to the Attributable Burden of Cardiovascular Diseases in Iran. Iranian J Publ Health 2012; 41(8): 50-55.[persion]